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Recently, exome sequencing led to the identification of causal mutations in 16–31% of patients 
with intellectual disability (ID), leaving the underlying cause for many patients unidentified. In this 
context, the noncoding part of the human genome remains largely unexplored. For many long non-
coding RNAs (lncRNAs) a crucial role in neurodevelopment and hence the human brain is anticipated. 
Here we aimed at identifying lncRNAs associated with neuronal development and ID. Therefore, we 
applied an integrated genomics approach, harnessing several public epigenetic datasets. We found 
that the presence of neuron-specific H3K4me3 confers the highest specificity for genes involved in 
neurodevelopment and ID. Based on the presence of this feature and GWAS hits for CNS disorders, we 
identified 53 candidate lncRNA genes. Extensive expression profiling on human brain samples and other 
tissues, followed by Gene Set Enrichment Analysis indicates that at least 24 of these lncRNAs are indeed 
implicated in processes such as synaptic transmission, nervous system development and neurogenesis. 
The bidirectional or antisense overlapping orientation relative to multiple coding genes involved in 
neuronal processes supports these results. In conclusion, we identified several lncRNA genes putatively 
involved in neurodevelopment and CNS disorders, providing a resource for functional studies.
Intellectual disability (ID) affects approximately 1–3% of the general population1 and can be caused by any condi-
tion that impairs the development and proper functioning of the human brain. Not only is ID a lifelong problem, 
it has a strong socio-economic impact on both patients and their families.
Both genetic and environmental factors play an important role in human cognition and hitherto, approx-
imately 28% of ID cases can be explained by genetic factors2. The diagnostic yield has increased significantly 
over the years, first through the implementation of genomic microarrays3 and more recently by the use of exome 
sequencing. Recently it was shown that in approximately 16–31% of patients with ID, a causal mutation in a 
known ID gene can be identified using a trio based exome sequencing approach4,5. In an additional ~20% of 
patients, a de novo mutation was identified in a new candidate ID gene4–6. Notwithstanding this progress, for the 
majority of patients the underlying cause of ID remains unexplained, thus warranting further research. Although 
whole genome sequencing has been used to identify pathogenic mutations7, the subsequent analysis mainly tar-
geted the coding part of the genome as our understanding of non-coding variation is still limited. As such, the 
non-coding part of the human genome remains largely unexplored. Recent evidence shows that a specific class 
of non-coding RNAs, so-called long non-coding RNAs (lncRNAs; defined as transcripts longer than 200 bp in 
length without protein coding potential) play important and diverse functions in gene regulation and protein 
interactions8–12. Of particular importance, many of these lncRNAs emerged recently during vertebrate and pri-
mate evolution and are anticipated to be of crucial importance in the most highly evolved and complex human 
organ, the brain13–15. Non-coding RNAs have indeed been linked to brain complexity and development with a 
possible role in brain cellular diversity, amongst others16–20.
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Moreover, a substantial percentage of disease association signals of genome wide association studies (GWAS) 
performed for many central nervous system (CNS) disorders, map to such expressed non-coding regions in the 
human genome21. From several studies, it has become apparent that these CNS disorders (e.g. schizophrenia and 
bipolar disorder) have a fundamental overlap in biological pathways with ID22–24. These pathways affect synapse 
formation and maintenance, neurotransmission, as well as chromatin regulation and organization. The dysfunc-
tion of specific neuronal networks underlying the particular symptoms of each clinical condition most likely 
depends on additional genetic, epigenetic, and environmental factors that remain to be characterized.
Previous studies have used microarray or RNA-seq expression profiling to identify lncRNAs that are upregu-
lated during neuronal development25,26 or differentially expressed in tissue samples of patients with autism spec-
trum disorders (ASD) or major depressive disorder (MDD)27–29. Additionally, in silico approaches have also been 
used to find noncoding antisense transcripts associated with ASD-genes30. In this study, we aimed to identify 
candidate lncRNAs associated with neuronal development and ID through an integrated genomics approach. By 
combining our in-house lncRNA database LNCipedia31 with publically available neuronal functional genomics 
data (H3K4me3 histon mark, REST binding and DNaseI hypersensitivity) we selected strong candidate genes for 
ID and neurodevelopmental disorders. These data respectively mark active promoters, neuronal genes silenced in 
nonneuronal tissues and transcriptionally active regions.
To test our hypothesis that these (epi) genetic features are relevant for the identification of candidate lncRNAs, 
we applied a validation strategy in which we selected RefSeq protein-coding genes and lncRNA transcripts char-
acterized by these features. Subsequently, we performed an enrichment analysis of GWAS hits for CNS disorders 
and, for the former gene set, known and candidate ID genes. Identification of the most relevant feature resulted 
in a list of candidate lncRNAs. This analysis was further complemented by extensive expression profiling of all 
protein-coding genes and ca. 23,000 lncRNA transcripts in 15 human tissues, among which 8 brain samples. 
Next to providing insights into overall expression patterns of lncRNAs in human brain regions, this allowed us to 
construct coexpression profiles for the identified lncRNAs. Through subsequent Gene Set Enrichment Analysis 
(GSEA) and exploration of the genomic neighbourhood we assigned putative biological functions to the selected 
lncRNAs.
Results
Enrichment analysis shows that neuron-specific H3K4 trimethylation confers the highest 
specificity for genes involved in ID and neurodevelopment. Since the function of most lncRNAs 
remains elusive, we tried to define a strategy to identify lncRNAs with a putative role in neuronal development 
and ID by combining several (epi) genomic and transcriptomic datasets (Overview in Fig. 1). Specifically, we 
identified protein-coding genes and lncRNAs that present with one of the following features in the promoter 
region (see Materials and Methods). (1) As a first mark, enriched H3K4me3 peaks in neuronal samples com-
pared to nonneuronal controls (short: neuron-specific H3K4me3), indicative for an active promoter region, were 
included. (2) Secondly, REST (RE1 Silencing Transcription factor) binding was included as one of the criteria, 
Figure 1. Overview of the strategy and selection process. Overview of the strategy followed in this paper 
to identify an appropriate filtering approach and select lncRNAs with a putative role in ID and neuronal 
development. Phase I: In order to identify an appropriate filtering strategy, an enrichment analysis of ID genes 
and GWAS hits was performed on sets of RefSeq protein-coding genes and LNCipedia lncRNA transcripts 
passing the following filters: set 1 = DNAse I hypersensitivity, set 2 = neuron-specific H3K4me3, set 3 = REST 
binding. Phase II: Microarray expression profiling of all protein-coding genes and 22,980 lncRNAs in 8 human 
brain samples and 7 other human tissues allowed us to calculate mRNA:lncRNA correlation for selected 
lncRNA transcripts. Subsequent Gene Set Enrichment Analysis and examination of the orientation relative to 
and function of cis coding genes provided insight into putative functions of the selected lncRNAs.
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since REST is involved in silencing neuronal genes in non-neuronal tissues32. (3) Finally, we included DNAse 1 
hypersensitivity in embryonic and neural cell lines as a mark for active transcription. The performance of these 
features to delineate genes involved in neuronal development and ID was assessed by selecting RefSeq pro-
tein-coding genes and LNCipedia lncRNA transcripts featured by these marks, followed by enrichment analysis 
for known and candidate ID genes in the former gene set (protein-coding genes), and for the presence of GWAS 
hits associated with CNS disorders in both resulting gene sets (protein-coding genes and lncRNAs) (Fig. 2).
Of the RefSeq coding genes (19,233 genes; 38,654 transcripts; UCSC February 2015) 12,696 presented with 
a REST binding motif and 7,003 with a neuron-specific H3K4me3 mark in the promoter region (Supplemental 
Table S3). 15,144 RefSeq genes showed DNAse 1 hypersensitivity in the promoter region (Supplemental 
Table S3). When performing the same analysis for lncRNAs (LNCipedia 2.1; 32,108 transcripts), 11,348 tran-
scripts present with a REST binding site in their putative promoter (Supplemental Table S4). A neuron specific 
H3K4me3 mark is present in the promoter region of 4,188 lncRNA transcripts and DNAse 1 hypersensitivity was 
observed in the promoter region of 17,023 transcripts (Supplemental Table S4). Although a significant enrich-
ment of ID genes was noted for all coding genes presenting with either a neuron-specific H3K4me3 modifi-
cation (p-value = 6.252*10−12), REST binding sites (p-value = 2.701–10−5) or DNAse 1 hypersensitive regions 
(p-value = 5.646* 10−4), the largest enrichment was observed for genes overlapping with neuron-specific 
H3K4me3 (Fig. 2 and Supplemental Table S3). When assessing genes containing selected GWAS hits, the 
H3K4me3 filter was the only one to result in a significant enrichment (p-value = 2.794* 10−8) (Fig. 2 and 
Supplemental Table S3). Enrichment for both ID genes and GWAS hits did not improve significantly when com-
bining the H3K4me3 mark with the two other features (Supplemental Table S3).
Taken together, these observations suggest that the neuron-specific H3K4me3 mark yields the highest speci-
ficity for genes involved in ID and neurodevelopment. This was also confirmed for the lncRNAs, since enrichment 
of lncRNAs harbouring a SNP associated with CNS disorders was only observed within the group of transcripts 
presenting with a neuron-specific H3K4me3 mark (p-value = 1.957* 10−3) (Fig. 2 and Supplemental Table S4).
The genomic neighbourhood of lncRNAs with a neuron-specific H3K4me3 mark. As many lncRNAs 
are known to perform their regulatory function in cis33, we subsequently examined the genomic neighbourhood 
of the resulting set of 4,188 lncRNAs with neuron-specifc H3K4me3 marks. Among these, 3,222 overlap with, 
or are transcribed within 5 kb from a protein-coding gene. Subsequently, we performed enrichment analysis of 
GO terms for these cis coding genes (geneontology.org). GO terms involved in positive regulation of biological 
processes and nervous system development are clearly represented (Supplemental Fig. S2, Supplemental Table S5). 
Additionally, among the 4,188 lncRNAs characterized by neuron-specific H3K4me3, 53 harbour a GWAS hit for 
CNS disorders within their sequence. As the presence of such a SNP directly implicates these loci in neuropatho-
genesis, we subsequently focussed our analyses on this set of 53 lncRNAs (list in Supplemental Table S6).
When zooming in on the genomic neighbourhood of these 53 lncRNAs, 44 overlap with, or are transcribed 
within 5 kb from, a protein-coding gene. Many of these are either transcribed bidirectionally from the same pro-
moter region as the coding gene (28 transcripts) or in an antisense manner covering a large part of the coding 
gene body (12 transcripts) (Supplemental Table S7). On the other hand, three selected transcript clusters and 
one single transcript are situated more than 50 kb away from the nearest protein-coding gene (lnc-C22orf32-1, 
lnc-AC073043.2.1-1, lnc-USP25-2 & lnc-DPYD-4:1) and are transcribed from alone-standing promoter regions 
characterized by their own H3K4me3 marks, DHS regions, transcription factor clusters and CpG islands.
Expression profiling of lncRNAs in neuronal and non-neuronal tissues. Extensive expression 
profiling of all protein-coding genes and ca. 23,000 lncRNA transcripts was performed for 15 different human 
Figure 2. Neuron-specific H3K4me3 confers the highest specificity for ID genes and genes harbouring 
GWAS hits. Enrichment of ID genes and GWAS hits associated with CNS disorders in resulting sets of protein-
coding genes and lncRNAs after applying REST binding sites, neuron-specific H3K4me3 marks, DNAseI 
hypersensitivity, upregulation in neuronal tissues & expression in at least one neuronal tissues (normalized log2 
transformed expression value (E) > 8) as filters. P-values were determined according to Fisher’s exact test. Odds 
ratios are indicated within the boxes.
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tissues: heart, adrenal gland, breast, kidney, lung, colon and liver were used as non-neuronal controls, while 8 
different brain samples were evaluated as neuronal tissues. Of the 4,188 lncRNA transcripts with a H3K4me3 
mark, 2,636 were covered on the custom designed array (30/53 transcripts overlapping with both a H3K4me3 
mark and a GWAS hit) (Supplemental Table S8). No unique probes could be designed for the other transcripts. 
First we assessed whether identifying upregulated genes in neuronal samples would confer sufficient specificity 
to delineate the lncRNAs involved in neurodevelopment and ID. The evaluation strategy we applied was the same 
as described above, i.e. assessing enrichment of ID genes in upregulated protein-coding genes and determining 
enrichment of genes harbouring a GWAS SNP for both upregulated protein-coding genes and lncRNAs.
RankProduct analysis of the protein-coding genes between neuronal and non-neuronal tissues revealed an 
upregulation of 1,290 and a downregulation of 790 genes (FDR 0.01) (Supplemental Table S8). Upregulated genes 
showed significant enrichment for both ID genes (124/1290, p = 3* 10−10) and genes harbouring GWAS hits 
(65/1290, p = 7.5* 10−14) (Fig. 2 and Supplemental Table S8). When considering lncRNAs, 731 and 237 transcripts 
were respectively up- and downregulated in neuronal tissues (FDR 0.01). However, only 4 upregulated lncRNAs 
harbour a GWAS hit (lnc-RP11-210M15.2.1-1:3, lnc-AC073043.2.1-1:1, lnc-APOB-8:1 & lnc-MYO10-1:1). Hence, 
when employing upregulation as a filter for the lncRNAs, no significant enrichment for transcripts comprising 
GWAS hits could be observed (4/731) (Fig. 2 and Supplemental Table S8).
Only 3 out of the 30 lncRNA transcripts presenting with a H3K4me3 mark and a GWAS associated SNP that 
were covered on the array, were significantly differentially expressed between brain regions and nonneuronal 
tissues. This might be explained by the fact that genes involved in neuronal development might have a different 
expression in fetal and adult whole brain as well as in different adult brain tissues. Moreover, it is well established 
that lncRNAs exhibit an overall lower expression than protein-coding genes (Fig. 3). This suggests that it might 
be more relevant to consider the expression profile of lncRNAs within single neuronal tissues instead of assessing 
differential expression between all brain tissues and nonbrain tissues. To account for this, we implemented a less 
stringent strategy consisting of a normalized log2 expression value > 8 in at least one brain sample, which cor-
responds approximately to the upper quartile of protein-coding expression values (Fig. 3A). For protein-coding 
genes, this again resulted in an enrichment of ID genes (839/11472, p-value = 6.9* 10−15) and genes harbouring 
GWAS hits (243/11472, p-value = 9* 10−4) (Fig. 2 and Supplemental Table S8). However, again no significant 
enrichment for lncRNAs containing GWAS hits was observed for the remaining lncRNA transcripts (5/1350) 
(Fig. 2 and Supplemental Table S8).
Predicting putative functions for lncRNAs with a neuron-specific H3K4me3 mark and harbour-
ing a SNP associated with CNS disorders. To identify putative functions for the 30 selected lncRNAs 
with expression data, we employed a guilt-by-association approach based on correlation in expression profiles 
with all protein-coding genes.
For each lncRNA, protein-coding genes were ranked according to their pairwise Spearman’s correlation coef-
ficient. Subsequently, these ranked lists were used to perform a preranked Gene Set Enrichment Analysis (GSEA). 
For 19 out of the 30 selected lncRNAs, gene sets highly enriched (abs(NES)> 2, FDR < 0.25) among the top 
positively correlated genes were linked to synaptic transmission, nervous system development or neurogenesis 
(example for the lncRNAs showing the strongest enrichment (lnc-MYO10-1:1, lnc-RASGRF1-1:6 & lnc-RP11-
210M15.2.1-1:3) in Fig. 4, all GSEA results in Supplemental Fig. S1). Five lncRNAs negatively correlate to genes 
involved in these neuronal processes, suggesting that these lncRNAs may be involved in suppressive regulation 
of such genes (example for lnc-C22orf32-1:4 in Fig. 4). For an additional three lncRNAs, highly correlated genes 
were involved in mitochondrial energy metabolism (Supplemental Fig. S1).
For 9 of the lncRNAs (lnc-MYO10-1 transcripts, lnc-RASGRF1-1 transcripts, lnc-C22orf32-1:4 & lnc-EIF6-1 
transcripts), the top ranked correlated protein-coding genes (absolute correlation coefficients higher than 0.7) 
were significantly enriched for (candidate) ID genes (Fig. 5 and Supplemental Table S9).
Among these 30 selected lncRNAs, 25 transcripts overlap with or are transcribed within 5 kb from the nearest 
protein-coding gene (Table 1). Ten out of the seventeen transcripts exhibiting bidirectional transcription show a 
significant, positive correlation (p < 0.05) in expression to their divergently transcribed, coding neighbour. Four 
out of the eight transcripts with an antisense overlapping transcription were significantly correlated; three in a 
negative fashion, one positively correlated. These observations suggest that bidirectionally transcribed and anti-
sense overlapping lncRNAs are primarily involved in, respectively, positive and negative regulation of cis-genes.
Discussion
Although literature states that lncRNAs might play an important role in neuronal development and/or intellec-
tual disability, until now, only a handful of these lncRNAs have been identified and functionally validated26,34–37. 
With the advent of next-generation sequencing and consortia such as ENCODE, large (epi)genetic data sets have 
become available. Here we integrated several publically available datasets and generated extensive expression data 
to get a holistic view of the potential of lncRNAs in neuronal development and CNS disorders.
To develop a strategy that permits the identification of genes involved in neuronal development and ID, we 
first applied multiple epigenomic features for all RefSeq protein-coding genes. This resulted in the most signifi-
cant enrichment of ID genes and genes associated with CNS disorders when applying neuron-specific H3K4me3 
as a feature. A large proportion of the known and candidate ID genes (581/1134) fulfilled this criterion, including 
several of our recently reported candidate ID genes such as MYT1L, DEAF1, CACNA2D1 and POU3F338–42. For 
those that do not present with neuron-specific trimethylation of H3K4, an explanation can be found in the func-
tion of these genes, as several of them (e.g. TGFBR1 & TWIST1) give rise to syndromal forms of ID, indicating 
these genes also play important roles outside of the CNS.
Using the neuron-specific H3K4me3 mark to identify lncRNAs with putative involvement in neurode-
velopment, resulted in a set of 4,188 lncRNA transcripts. This set includes almost all lncRNAs that have been 
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demonstrated in literature to play a role in neuronal development, such as MIAT, TUG1, DGCR5, MEG3, and 
TUNA26,37,43–46. One lncRNA with validated function during neurogenesis that is notably absent in our candidate 
list is RMST35. Although brain specific expression, REST binding and DNAse 1 hypersensitivity were noted for 
RMST, no neuron specific H3K4me3 was observed. However, RMST plays an important role in neuronal differ-
entiation through association with SOX2, which has a neuron specific H3K4me3 mark. Also the lncRNA PNKY47, 
although presenting with a neuron specific H3K4me3 mark, was not selected through our strategy as this tran-
script was not included in LNCipedia v2.1.
Although the expression data for neuronal and nonneuronal tissues were highly informative for the selection 
of protein-coding genes (upregulated genes showed very strong enrichment for ID genes and GWAS hit loci), 
Figure 3. lncRNAs display lower overall expression compared to protein coding genes. mRNA vs lncRNA 
expression levels. Boxplots of normalized log2 expression values in the 15 tested tissues. (A) Coding genes  
(B) lncRNAs. The data for neural and nonneuronal tissues is respectively shown in red and blue.
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enrichment analysis suggested them to be poor filters for lncRNAs. This might be explained by their overall lower 
and more region-specific expression profile, which renders differential expression between groupings of multiple 
regions/tissues both less pronounced and less relevant.
From our 30 selected lncRNAs measured on the microarray that present with a neuron-specific H3K4me3 
mark and overlap with a SNP associated with CNS disorders, respectively 19 and 5 appear to have a highly 
correlated or anticorrelated expression profile with genes involved in neuronal development. As postulated by 
Mestdagh et al., strong correlation in expression profiles is indicative for a role in the same cellular processes, 
implying that the lncRNAs selected here are indeed involved in networks related to neuronal development and 
functioning48. Additionally, of these 30, twenty-five candidates overlap with, or are transcribed within 5 kb 
from a protein-coding gene (Table 1). Among them, 17 are transcribed bidirectionally from the same promoter 
region as the neighbouring protein-coding gene. Interestingly, bidirectional transcription has been associated 
with genes exhibiting tissue-specific expression patterns49. Hence, it is unsurprising that a large portion of the 
selected lncRNAs exhibit such head-to-head transcription, as these were selected based on neuron-specific activ-
ity (predicted by neuron-specific H3K4me3). Transcription of ten out of the seventeen bidirectional candidates 
positively correlates with mRNA expression of the neighbouring coding gene (Table 1). This is in concord-
ance with previous observations that bidirectionally transcribed ncRNAs show a coordinated expression with 
their mRNA counterpart13,49,50. This at least implies a coordinated regulation of both lncRNA and mRNA, and 
hence an involvement in the same biological processes. Moreover, this could point towards these lncRNAs func-
tioning as transcriptional activators of the corresponding mRNA51,52. Clearly exemplifying this is the report by 
Boque-Sastre et al., which showed that a bidirectionally transcribed lncRNA, VIM-AS, promotes VIM transcrip-
tion through R-loop formation at the VIM TSS52.
Figure 4. Gene set enrichment analysis links selected genes to neuronal processes. Normalized enrichment 
scores (NES) of the top 10 positively and negatively enriched genes sets (abs(NES) > 2 & FDR < 0.25) among 
protein-coding genes highly (anti-)correlated to lnc-MYO10-1:1, lnc-RASGRF1-1:6, lnc-RP11-210M15.2.1-1:3 
& lnc-C22orf32-1:4. A positive NES reflects enrichment of the gene set at the top of the ranked list, i.e. genes 
highly, positively correlated to the lncRNA in question. Gene sets with a negative NES are overrepresented at the 
bottom of the gene list, i.e. among negatively correlated protein-coding genes. These results can also be found in 
Supplemental Table S10, which, next to the NES, also displays non-abbreviated gene set names, gene set sizes, 
enrichment scores and FDR q-values.
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Our bidirectionally transcribed candidates show divergent transcription to ANKRD34C (lnc-RASGRF1-1 
transcripts), SLC17A6 (lnc-FANCF-3:1), NRXN1 (lnc-CHAC2-4:1), ARNT2 (lnc-RP11-210M15.2.1-1 tran-
scripts) & BASP1 (lnc-MYO10-1 transcripts) (Fig. 6), suggesting a possible role in cis-regulation of these genes. 
The function of ANKRD34C is currently unknown, but for the other genes, a clear link with brain or neurodevel-
opment has been reported. SLC17A6 (Solute Carrier Family 17 member 6) is a vesicular glutamate transporter53. 
NRXN1 (neurexin 1) has been implicated in schizophrenia and plays an important role in the nervous system 
by mediating, among others, cell-cell interactions and signal transmission54. BASP1 (brain abundant, membrane 
attached signal protein 1) is specifically expressed in nervous tissue and ARNT2 (aryl-hydrocarbon receptor 
nuclear translocator 2) encodes a transcription factor involved in neurodevelopmental processes, neuronal con-
nectivity and cellular responses to hypoxia55.
Overlapping antisense lncRNAs are traditionally associated with regulation through lncRNA-DNA or 
lncRNA-mRNA duplex formation, facilitating chromatin modulation, transcriptional interference, splicing 
inhibition, mRNA editing and stability control of the associated protein-coding gene56. Lnc-EIF6-1 transcripts 
overlap matrix metalloproteinase-24 (MMP24, a.k.a. MT5-MMP) in an antisense manner (Table 1 and Fig. 6). 
MMP24 is a key regulator of neural stem cell (NSC) quiescence and promotes NSC activation by cleavage of 
Figure 5. Highly correlated coding genes show enrichment for ID genes. Enrichment of ID genes among 
top correlated (abs(correlation) > 0.7) protein-coding genes for each of the selected lncRNAs. The dotted line 
represents a q-value cut-off of 0.05.
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N-cadherin57. The two negatively correlated lnc-EIF6-1 transcripts (Table 1), suggest that lnc-EIF6-1 activation 
may play a role in promoting NSC quiescent state maintenance by downregulating MMP24.
In conclusion, we identified several lncRNAs putatively involved in neural development. Based on an inte-
grated approach combining epigenetic marks, GWAS hits for CNS disorder, guilt-by-association through GSEA, 
correlation to ID genes and orientation relative to protein-coding genes with known function in neuronal devel-
opment, several strong candidates for further functional validation were revealed. Moreover, while we did not 
perform an in depth analysis of the resulting sets of protein-coding genes, this strategy should also prove to be 
an interesting approach to identify new coding genes involved in neural development and intellectual disability.
Methods
For all analyses regarding both coding and non-coding genes, the RefSeq coding genes catalogue (GRCh37/hg19; 
genome.ucsc.edu) and LNCipedia.2.1 (www.lncipedia.org) were used. The approach implemented here to select 
lncRNAs was also applied to RefSeq protein-coding genes as a validation strategy.
Neuron specific histone modifications. Publically available data regarding maps of histone H3K4me3 
in human brain were used. These data were generated using chromatin immunoprecipitation followed by 
high-throughput sequencing (ChIP-seq)58–60. Specifically, data from neuronal nuclei from the prefrontal cor-
tex of 11 individuals and three lymphocyte control samples were used. 7947 regions, enriched in H3K4me3 
in all 11 neuronal samples compared to the lymphocytes, are available through the UCSC genome browser as 
neuron-specific brain histone H3K4me3 peaks (UMMS Brain Hist Track; hg19)58. We called a neuron-specific 
H3K4me3 peak proximal to the promoter if it resided within 5 kb of the transcription start site (TSS).
lncRNA transcript distance (bp) protein-coding gene correlation orientation
lnc-NDUFAF2-2:1 0 SMIM15 NOT ON ARRAY Bidirectional
lnc-RASGRF1-1:1 0 ANKRD34C 0.72 Bidirectional
lnc-RASGRF1-1:4 0 ANKRD34C 0.62 Bidirectional
lnc-RASGRF1-1:2 0 ANKRD34C NOT SIGN Bidirectional
lnc-RASGRF1-1:7 0 ANKRD34C 0.66 Bidirectional
lnc-RASGRF1-1:5 0 ANKRD34C 0.62 Bidirectional
lnc-RASGRF1-1:3 0 ANKRD34C 0.58 Bidirectional
lnc-RASGRF1-1:8 0 ANKRD34C NOT SIGN Bidirectional
lnc-RASGRF1-1:6 0 ANKRD34C 0.84 Bidirectional
lnc-MYO10-1:1 0 BASP1 0.79 Bidirectional
lnc-MYO10-1:2 0 BASP1 0.89 Bidirectional
lnc-MRE11A-1:1 0 FUT4 − 0.64 Overlapping antisense
lnc-MRE11A-1:2 0 FUT4 NOT SIGN Overlapping antisense
lnc-CHAC2-4:1 64 NRXN1 NOT SIGN Bidirectional
lnc-C22orf32-1:2 54418 TCF20 − 0.66 free-standing promoter region
lnc-C22orf32-1:4 59298 TCF20 NOT SIGN free-standing promoter region
lnc-C22orf32-1:3 54426 TCF20 NOT SIGN free-standing promoter region
lnc-EIF6-1:6 0 MMP24 − 0.59 Overlapping antisense
lnc-EIF6-1:8 0 MMP24 NOT SIGN Overlapping antisense
lnc-EIF6-1:11 0 MMP24 NOT SIGN Overlapping antisense
lnc-EIF6-1:5 0 MMP24 NOT SIGN Overlapping antisense
lnc-EIF6-1:2 0 MMP24 − 0.52 Overlapping antisense
lnc-EIF6-1:7 0 MMP24 0.63 Overlapping antisense
lnc-ELF2-2:1 3112 CCRN4L NOT SIGN Bidirectional
lnc-RP11-210M15.2.1-1:1 236 ARNT2 0.77 Bidirectional
lnc-RP11-210M15.2.1-1:3 502 ARNT2 0.79 Bidirectional
lnc-FANCF-3:1 0 SLC17A6 NOT SIGN Bidirectional
lnc-ANKMY1-2:1 16 CAPN10 NOT SIGN Bidirectional
lnc-AC073043.2.1-1:2 60082 C2orf69 NOT SIGN free-standing promoter region
lnc-AC073043.2.1-1:1 60079 C2orf69 0.61 free-standing promoter region
Table 1.  Distance towards closest protein-coding gene for the 30 selected lncRNAs that were covered on 
the array. Also includes Spearman’s correlation coefficient (if associated protein-coding gene was covered on 
the array and correlation was significant) and orientation of transcription relative to the nearest protein-coding 
gene. NOT SIGN = not significant.
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REST binding. ENCODE ChIP-seq data for the transcription factor REST was used through the UCSC track 
Integrated Regulation from ENCODE (hg19). REST ChIP-seq data from all 91 cell lines was consulted61–63. As for 
H3K4Me3, REST binding in the promoter region was called if, for at least one cell line, a REST peak was located 
within 5 kb of the TSS.
DNAse 1 hypersensitivity. DNAse-seq data from twelve selected cell lines from the ENCODE project were 
used64,65. These twelve selected cell lines comprised 4 embryonic stem cell lines, 4 astrocyte cell lines, 3 neuroblas-
toma cell lines and 1 glioblastoma cell line. We only considered DNAse 1 hypersensitivity in the promoter region, 
again defined within 5 kb of the TSS in at least one of the twelve selected cell lines.
Enrichment of ID genes and GWAS hits. Upon the identification of RefSeq coding genes and LNCipedia 
lncRNA transcripts featured by the epigenetic features mentioned above, these gene sets were subsequently 
interrogated for, respectively the presence of both ID genes and GWAS hits, and GWAS hits alone. Here we use 
the presence of ID genes and GWAS hits among RefSeq protein-coding genes as a validation strategy for the 
approach proposed here. As source of known and candidate ID genes, the gene lists from Gilissen et al.7 were used 
(Supplemental Table S1).
To evaluate the presence of GWAS hits, the full Catalogue of published genome wide association studies 
was downloaded (http://www.ebi.ac.uk/gwas/, version April 2015) and filtered for SNPs associated with central 
nervous system disorders such as autism, attention deficit hyperactivity disorder, bipolar disorder, epilepsy 
and schizophrenia, resulting in 1071 SNPs (Supplemental Table S2). A SNP is mentioned as overlapping with 
a coding gene or lncRNA, if it is located within the start and end position of a gene, regardless whether it is 
intronic or exonic.
Enrichment of the gene sets for ID genes and GWAS hits was statistically evaluated using Fisher’s exact test at 
the 0.05 significance level.
Expression Profiling. Total RNA from 15 human fetal and adult tissues was obtained commercially from 
Stratagene Europe (Amsterdam, the Netherlands) and Agilent (Diegem, Belgium). Samples included whole 
brain, colon, heart, kidney, liver, lung, breast and adrenal gland (Stratagene Europe; all adult tissues); cerebellum, 
brain stem, striatum, frontal cortex, occipital cortex, parietal cortex (Agilent; adult tissues) and fetal whole brain 
(Agilent). Expression analysis was performed according to the manufacturer’s instructions with 100 ng RNA as 
input, using an in-house designed custom array (SurePrint G3 Human Gene Expression array v2 (AMADID 
041648; Agilent Technologies, Santa Clara, CA, USA)) covering all protein coding genes and 22980 lncRNA tran-
scripts (LNCipedia version 2.1). Normalization of these data was performed using the VSN package (v3.38) in R/
Bioconductor (BioC v3.2). Normalized expression values were log2 transformed.
Differential expression analysis between brain and nonneuronal tissues was performed through Rank Product 
statistical analysis66 in R/Bioconductor, using the RankProd package (v2.42) with 1000 permutations and a false 
discovery rate (FDR) ≤ 0.01.
The expression data have been submitted to the GEO repository (accession number GSE81410).
Predict putative functions of lncRNAs through guilt-by-association approach. To infer relevant 
biological pathways for identified lncRNAs, the microarray data were also used to create a correlation matrix by 
calculating Spearman’s Rank correlation coefficient for each lncRNA:mRNA pair. Subsequently, a ranked list of 
Figure 6. Orientation of lncRNAs relative to the nearest protein-coding gene. An example of bidirectionally 
transcribed and antisense overlapping lncRNAs. (A) lnc-MYO10-1:1 is transcribed bidirectionally to BASP1. 
(B) The lnc-EIF6-1 transcripts are transcribed in an antisense manner to MMP24 and overlap the entire 
MMP24 transcript body. The grey box represents the neuron-specific H3K4me3 mark. SNPs within this region 
are shown at the bottom.
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mRNAs was generated for each of these lncRNAs, based on the Spearman’s rho-value. These ranked lists were 
subsequently analyzed using preranked Gene Set Enrichment Analysis (http://www.broadinstitute.org/gsea/)67. 
GSEA was performed using the BioCarta, Kegg and Reactome Gene sets as well as the Gene Ontology gene sets 
from the Molecular Signature Database (MSigDB). Gene Sets with an absolute normalized enrichment score 
abs(NES) ≥ 2 and a false discovery rate FDR ≤ 0.25 were selected.
Enrichment of ID genes among top correlated genes. For each of the selected lncRNAs, 
protein-coding genes with an absolute pairwise Spearman’s correlation coefficient > 0.7 were used. Fisher’s exact 
test was used to determine enrichment of ID genes among these genes, q-values were calculated according to the 
method of Benjamini & Hochberg68. A q-value cut-off of 0.05 was used to call lncRNAs with a significant enrich-
ment of ID genes among the top correlated genes.
Exploration of the genomic neighbourhood of lncRNA genes. For all selected lncRNAs the 
nearest protein-coding gene was determined in R using the GenomicRanges package. For each overlapping 
protein-coding gene and the protein-coding genes that are transcribed within 5 kb of the lncRNA, a gene ontology 
(GO) enrichment using PANTHER69 was performed with visualisation using REVIGO70.
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